Literature DB >> 2319407

Serum-soluble interleukin-2 receptor levels in Kawasaki disease.

B A Lang1, E D Silverman, R M Laxer, V Rose, D L Nelson, L A Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2319407     DOI： 10.1016/s0022-3476(05)81610-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

Review 1.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.

Authors:  D Y Leung
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

2.  Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease.

Authors:  Nadine F Choueiter; Aaron K Olson; Danny D Shen; Michael A Portman
Journal:  J Pediatr       Date:  2010-07-27       Impact factor: 4.406

3.  Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells.

Authors:  M Sakaguchi; H Kato; A Nishiyori; K Sagawa; K Itoh
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

4.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.

Authors:  J Abe; B L Kotzin; K Jujo; M E Melish; M P Glode; T Kohsaka; D Y Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

5.  Elevation of soluble interleukin-2 receptor levels in nasal allergy.

Authors:  K Hisamatsu; T Ganbo; T Nakazawa; S Horiguchi; S Shimomura; Y Murakami
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

6.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

7.  Detection of soluble interleukin-2 receptor and soluble intercellular adhesion molecule-1 in the effusion of otitis media with effusion.

Authors:  T Ganbo; K I Hisamatsu; H Inoue; K Kikushima; A Mizukoshi; Y Murakami
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

8.  Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease.

Authors:  Sungho Cha; Minjeong Yoon; Yongjoo Ahn; Miyoung Han; Kyung-Lim Yoon
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.